Zobrazeno 1 - 3
of 3
pro vyhledávání: '"José M. Mariz"'
Publikováno v:
HemaSphere, Vol 7, p e7469294 (2023)
Externí odkaz:
https://doaj.org/article/0c0e6c0ee7ea4a80acd07eff0b6dfd88
Autor:
Nuno Cerveira, Bruno Loureiro, Susana Bizarro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, Rui Santos, Dulcineia Pereira, Cláudia Moreira, Sérgio Chacim, Nélson Domingues, Ana Espírito-Santo, Isabel Oliveira, Ilídia Moreira, Luísa Viterbo, Ângelo Martins, Manuel R. Teixeira, José M. Mariz
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Most patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) will relapse if treatment is withdrawn, but various trials have recently demonstrated that a significant proportion of patients who a
Externí odkaz:
https://doaj.org/article/844beabb6bfa4c04860691966de11379
Publikováno v:
Current treatment options in oncologyReferences and Recommended ReadingPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 22(6)
ABL1 tyrosine kinase inhibitors (TKI) have dramatically improved the outcome for CML (chronic myeloid leukemia) patients. When TKI therapy is addressed appropriately, it can lead to an optimal molecular response in the majority of CML patients and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4ed6061e7a6393208a9f2d5baa409b7
https://pubmed.ncbi.nlm.nih.gov/33866455
https://pubmed.ncbi.nlm.nih.gov/33866455